Heartflow, Inc.
No enriched coverage for $HTFL in the last 7 days.
No SEC Form 4 filings for $HTFL in the last 30 days.
Heartflow has filed a lawsuit against its competitor Cleerly, alleging misuse of AI technology in cardiology. The article is a brief news report from Reuters, distributed by Refinitiv.
This page on Stock Titan provides comprehensive details on HEARTFLOW INC (HTFL) SEC filings, including 10-K annual reports, 10-Q quarterly reports, and 8-K material event forms. It highlights the company's business as a medical technology firm using AI for coronary artery disease detection and management, and offers AI-powered summaries of complex sections. The site also includes recent insider transaction reports and conversion details for pre-IPO securities.
Heartflow, Inc. announced that its management will participate in a fireside chat at the Morgan Stanley Technology, Media & Telecom Conference on March 3, 2026. The company specializes in AI technology for coronary artery disease (CAD), having adopted its technology in over 1,400 institutions globally. Heartflow's platform transforms coronary CTA images into personalized 3D heart models, offering crucial insights without invasive procedures.
